P-137 Efficacy and safety of atezolizumab plus bevacizumab in unresectable or advanced hepatocellular carcinoma: Real life data from 5 Swiss centers
Norero, B., Siebenhuener, A., Kössler, T., Usdin, N., Semela, D., Stillhard, R., Meyer-Herborn, P., Bergamin, I., Fritsch, R., Kremer, A., Blümel, S., Hussung, S., Schwacha-Eipper, B.
Published in Annals of oncology (01.06.2022)
Published in Annals of oncology (01.06.2022)
Get full text
Journal Article